September 03, 2026

Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems

Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today announced that it has received...

recent articles

Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today...

Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a...

From Leica Biostystems on LinkedIn: We're excited to share the next milestone in our collaboration with Mindpeak bringing powerful AI tools closer to researchers through the Aperio AI Store. Six Mindpeak algorithms are now available on...

From the FormaPath blog: FormaPath was honored to be featured by Mecademic Industrial Robotics, highlighting the integration of the Meca500 robotic arm within the nToto platform. By combining Mecademic's micrometer-level precision robotics...

From Indica Labs: No matter their organizational setting, digital pathology cores routinely provide researchers with access to advanced imaging and analysis capabilities and institutional expertise that expand the possibilities of scientific...

Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a...

OR

platinum partners

gold partners

Silver Partners

Media Partners